{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T03:15:19Z","timestamp":1794971719059,"version":"4.9.1"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"13","license":[{"start":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T00:00:00Z","timestamp":1617321600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Eosinophilic fasciitis (EF) is an uncommon connective tissue disorder characterized by limb and trunk erythema, with symmetrical thickening of the skin. Its pathogenesis is poorly understood. Treatment consists mainly of glucocorticoids. Yet, no randomized trials have evaluated therapies for this rare disease and the optimal treatment modality remains unclear. Although most patients show partial or complete response to glucocorticoids, many relapse upon drug tapering, while others either do not respond at all or fail to sustain prolonged remission. Second-line therapy for this rare disorder includes mainly methotrexate (MTX), azathioprine, cyclosporine and hydroxychloroquine. Recently, several attempts using rituximab and intravenous immunoglobulins (IVIG) have shown good clinical results.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>The three patients had good clinical response to glucocorticoid treatment, followed by disease flare when the drug dose was tapered. Adding methotrexate in all patients and azathioprine to patient 3 did not lead to remission.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>EF was diagnosed in all patients based on clinical presentation accompanied by fascia biopsy that demonstrated eosinophilic fasciitis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>The patients were successfully treated with rituximab or IVIG, achieving sustained remission.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The three cases had good clinical response to glucocorticoid treatment, followed by disease flare when the drug dose was tapered. The patients were then successfully treated with rituximab or IVIG, achieving sustained remission.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>This review of three cases of EF supports the results of previous reports, suggesting addition of rituximab and IVIG is an effective treatment for patients with refractory disease.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000025359","type":"journal-article","created":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T13:00:09Z","timestamp":1617195609000},"page":"e25359","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":16,"title":["Clinical experience with biologic treatment in resistant eosinophilic fasciitis"],"prefix":"10.1097","volume":"100","author":[{"given":"Daniel","family":"Erez","sequence":"first","affiliation":[{"name":"Department of Medicine D, Meir Medical Center, Kfar Saba"},{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehuda","family":"Shoenfeld","sequence":"additional","affiliation":[{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv"},{"name":"St. Petersburg State University, St. Petersburg, Russia"},{"name":"Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman","family":"Natour","sequence":"additional","affiliation":[{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv"},{"name":"Department of Medicine E, Meir Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zamir","family":"Dovrish","sequence":"additional","affiliation":[{"name":"Department of Medicine D, Meir Medical Center, Kfar Saba"},{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oshrat E.","family":"Tayer-Shifman","sequence":"additional","affiliation":[{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv"},{"name":"Rheumatology Service, Meir Medical Center, Kfar Saba, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8994-6497","authenticated-orcid":false,"given":"Yair","family":"Levy","sequence":"additional","affiliation":[{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv"},{"name":"Department of Medicine E, Meir Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,4,2]]},"reference":[{"key":"R1-20250524","first-page":"70","article-title":"Diffuse fasciitis with eosinophilia: a new syndrome?","volume":"88","author":"Shulman","year":"1975","journal-title":"Trans Assoc Am Physicians"},{"key":"R2-20250524","first-page":"569","article-title":"Diffuse fasciitis with hypergammaglobulinemia and eosinophilia: a new syndrome?","volume":"11","author":"Shulman","year":"1974","journal-title":"J Rheumatol"},{"key":"R3-20250524","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1007\/s10067-006-0525-6","article-title":"Eosinophilic fasciitis: report of two cases and a systematic review of the literature dealing with clinical outcomes that predict outcome","volume":"26","author":"Endo","year":"2007","journal-title":"Clin Rheumatol"},{"key":"R4-20250524","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0049-0172(88)90008-X","article-title":"Eosinophilic fasciitis: clinical spectrum and therapeutic response in 52 cases","volume":"17","author":"Lakhanpal","year":"1988","journal-title":"Semin Arthritis Rheum"},{"key":"R5-20250524","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-4632.2007.03544.x","article-title":"Eosinophilic fasciitis: demographics, disease pattern and response to treatment: report of 12 cases and review of the literature","volume":"47","author":"Bischoff","year":"2008","journal-title":"Int J Dermatol"},{"key":"R6-20250524","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s12016-015-8485-8","article-title":"Eosinophilic skin diseases: a comprehensive review","volume":"50","author":"Long","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"R7-20250524","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1159\/000018271","article-title":"Eosinophilic fasciitis following idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia and Hashimoto's disease","volume":"199","author":"Bachmeyer","year":"1999","journal-title":"Dermatol"},{"key":"R8-20250524","first-page":"1185","article-title":"Eosinophilic fasciitis associated with autoimmune thyroid disease and myelodysplasia treated with pulsed methylprednisolone and antihistamines","volume":"140","author":"Farrell","year":"1999","journal-title":"Br J Dermatol"},{"key":"R9-20250524","first-page":"96","article-title":"Eosinophilic fasciitis with thyroid disease","volume":"6","author":"Imren","year":"1988","journal-title":"Clin Exp Rheumatol"},{"key":"R10-20250524","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.berh.2012.08.001","article-title":"Eosinophilic fasciitis (Shulman disease)","volume":"26","author":"Lebeaux","year":"2012","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"R11-20250524","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/rheumatology\/ker366","article-title":"Eosinophilic fasciitis (Shulman disease): new insights into the therapeutic management from a series of 34 patients","volume":"51","author":"Lebeaux","year":"2012","journal-title":"Rheumatol (Oxford)"},{"key":"R12-20250524","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s10067-005-1099-4","article-title":"Eosinophilic fasciitis successfully treated with cyclosporine","volume":"24","author":"Bukie","year":"2005","journal-title":"Clin Rheumatol"},{"key":"R13-20250524","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/BF02032344","article-title":"Diffuse (eosinophilic) fasciitis. a series of six cases","volume":"3","author":"De Jonge-Bok","year":"1984","journal-title":"Clin Rheumatol"},{"key":"R14-20250524","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1093\/rheumatology\/keq062","article-title":"Infliximab may be effective in the treatment of steroid-resistant eosinophilic fasciitis: report of three cases","volume":"49","author":"Khanna","year":"2010","journal-title":"Rheumatology"},{"key":"R15-20250524","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3109\/03009747909114628","article-title":"Eosinophilic fasciitis. review and report of six cases","volume":"8","author":"Nassonova","year":"1979","journal-title":"Scand J Rheumatol"},{"key":"R16-20250524","first-page":"65","article-title":"Rituximab in refractory autoimmune diseases: Brazilian experience with 29 patients (2002-2004)","volume":"24","author":"Scheinberg","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"R17-20250524","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1001\/archderm.144.7.845","article-title":"Dapsone treatment for eosinophilic fasciitis","volume":"144","author":"Smith","year":"2008","journal-title":"Arch Dermatol"},{"key":"R18-20250524","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S1297-319X(03)00100-3","article-title":"Association of Shulman's syndrome and morphea: a case report","volume":"70","author":"Sabbagh","year":"2003","journal-title":"Joint Bone Spine"},{"key":"R19-20250524","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000093847","article-title":"Eosinophilic fasciitis 30 years after- what do we really know?","volume":"213","author":"Antic","year":"2006","journal-title":"Dermatol"},{"key":"R20-20250524","first-page":"307","article-title":"Value of immunoglobulins in Schulman fasciitis","volume":"29","author":"Bani-Sadr","year":"2000","journal-title":"Presse Med"},{"issue":"(suppl 1)","key":"R21-20250524","doi-asserted-by":"crossref","first-page":"109s","DOI":"10.1016\/S0248-8663(01)83504-9","article-title":"Use of intravenous immunoglobulins during corticoresistant Shulman fasciitis? [in French]","volume":"22","author":"Barrier","year":"2001","journal-title":"Rev Med Interne"},{"key":"R22-20250524","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jbspin.2009.06.001","article-title":"Intravenous immune globulines to treat eosinophilic fasciitis: a case report","volume":"76","author":"Pimenta","year":"2009","journal-title":"Joint Bone Spine"},{"key":"R23-20250524","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/MD.0b013e3182899e78","article-title":"Severe aplastic anemia associated with eosinophilic fasciitis","volume":"92","author":"de Masson","year":"2013","journal-title":"Medicine"},{"key":"R24-20250524","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/ijd.13940","article-title":"Rituximab as a therapeutic consideration for refractory eosinophilic fasciitis","volume":"57","author":"Nahhas","year":"2018","journal-title":"Int J Dermatol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000025359","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T17:09:47Z","timestamp":1748106587000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000025359"}},"subtitle":["Case reports and review of the literature"],"short-title":[],"issued":{"date-parts":[[2021,4,2]]},"references-count":24,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000025359","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,2]]},"assertion":[{"value":"2021-01-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}